Log in to save to my catalogue

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3726719

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

About this item

Full title

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Neurology, 2013-02, Vol.9 (2), p.106-118

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The ε4 allele of the apolipoprotein E (APOE) gene is the strongest genetic risk factor for Alzheimer disease (AD). Guojun Bu and colleagues describe the pathogenic links between Apo-E4 and neurodegeneration, including amyloid-β-dependent mechanisms and impairment of neurovascular function. The authors suggest potential strategies to target Apo-E, w...

Alternative Titles

Full title

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3726719

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3726719

Other Identifiers

ISSN

1759-4758

E-ISSN

1759-4766

DOI

10.1038/nrneurol.2012.263

How to access this item